The article discusses the high costs of weight loss drugs wegovy and zepbound, citing a study from the university of chicago which found that wegovy would need an 80% price cut to be deemed cost-effective, while zepbound would require nearly a 33% reduction.

Mentioned as a weight loss drug by novo nordisk.

Mentioned as a weight loss drug by eli lilly.

The institution where the research study was conducted.

The manufacturer of wegovy.

The manufacturer of zepbound.